Liver Cancer Research Symptoms Treatment

Liver Cancer or Hepatic Cancer is a cancer that originates in the liver. Liver cancers are malignant tumors that grow on the surface or inside the liver. Liver tumors are discovered on medical imaging equipment (often by accident) or present themselves symptomatically as an abdominal mass, abdominal pain, jaundice, nausea or liver dysfunction. Liver cancers should not be confused with liver metastases, which are cancers that originate from organs elsewhere in the body and migrate to the liver.

Free Advertising - Get millions of visitors for your website for FREE!

The Most Frequent Liver Cancer is hepatocellular carcinoma (HCC) (also named hepatoma, which is a misnomer because adenomas are usually benign). This tumor also has a variant type that consists of both HCC and cholangiocarcinoma components. The cells of the bile duct coexist next to the bile ducts that drain the bile produced by the hepatocytes of the liver. Cancers which arise from the blood vessel cells in the liver are known has hemangioendotheliomas.

---

****************************** Rarer Forms of Liver Cancer Include: mesenchymal tissue Sarcoma Hepatoblastoma, a rare malignant tumor, primarily developing in children. Most of these tumors form in the right lobe. Cholangiocarcinoma (bile duct cancers), which account for 1 or 2 out of every 10 cases of liver cancer. These cancers start in the small tubes (called bile ducts) that carry bile to the intestine. Angiosarcoma and hemangiosarcoma: These are rare forms of cancer that start in the blood vessels of the liver. These tumors grow quickly. Often by the time they are found they are too widespread to be removed. Most patients do not live more than a year after diagnosis. Lymphoma of liver: A rare form of lymphoma that usually have diffuse infiltration to liver. It may also form a liver mass in rare occasions.

---

Tweet-for-Cash with SponsoredTweets

Hepatitis C, liver cancer research at UNC secures $2.3M federal grant

The hepatitis C virus is believed to have links to the growth of liver cancer, but those connections have been hard to study. University of North Carolina at Chapel Hill research aimed at learning more about those connections has secured a $2.35 million federal grant. The five-year grant from the National Cancer Institute will enable two [...]

MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro ...

WOONSOCKET, R.I., May 16, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (MCET.OB) is pleased to announce representatives from the Company will present preclinical research findings ...

Van Andel Institute leads breakthrough research into deadly form of liver cancer

The international research effort identifies gene mutations in bile duct cancer.

Breakthrough in bile duct cancer with discovery of new gene mutations

Scientists have made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop.

Significant breakthrough in understanding the cause of bile duct cancer

A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.

Scientists make breakthrough in bile duct cancer with discovery of new gene mutations

( Van Andel Research Institute ) A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature ...

BioAlliance Pharma SA: Initiation of ReLive, phase III clinical trial with Livatag® In primary liver cancer

PARIS--(BUSINESS WIRE)--BioAlliance Pharma_Démarrage de ReLive, essai clinique de phase III de Livatag® dans le cancer primitif du foie

Liver cancer cited in death of Thai text prisoner

A preliminary autopsy shows liver cancer killed a Thai prisoner who was serving a 20-year term for sending insulting text messages about Thailand's royal family.

Autopsy indicates liver cancer killed Thai prisoner serving 20-year term for texting insults

A preliminary autopsy shows liver cancer killed a Thai prisoner who was serving a 20-year term for sending insulting text messages about Thailand's royal family.

Fighting back: Facing end-stage liver cancer, Hecky Powell makes comeback of his life

“I’ve got two birthdays now,” he said recently. Powell’s liver donor, James Copeland, who was 35 at the time of the procedure, works construction in Burnsville, Minn. A physical fitness enthusiast, Copeland donated a portion of his healthy liver to Powell, who had been diagnosed with end-stage liver cancer. The 11-hour procedure took place at Northwestern Memorial Hospital in Chicago. “This ...

Source: